Association of oxidative stress and memory performance in postmenopausal women receiving estrogen-progestin therapy

被引:0
|
作者
Shafin, Nazlahshaniza [1 ]
Zakaria, Rahimah [1 ]
Hussain, Nik Hazlina Nik [2 ]
Othman, Zahiruddin [3 ]
机构
[1] Univ Sains Malaysia, Dept Physiol, Kubang Kerian 16150, Kelantan, Malaysia
[2] Univ Sains Malaysia, Womens Hlth Dev Unit, Kubang Kerian 16150, Kelantan, Malaysia
[3] Univ Sains Malaysia, Dept Psychiat, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia
关键词
Estrogen-progestin therapy; Postmenopause; Oxidative stress; Malay Version of Auditory Verbal Learning Test; HORMONE REPLACEMENT THERAPY; SURGICALLY MENOPAUSAL WOMEN; MILD COGNITIVE IMPAIRMENT; EARLY ALZHEIMERS-DISEASE; CEREBRAL-BLOOD-FLOW; LIPID-PEROXIDATION; NEURODEGENERATIVE DISORDERS; ANTIOXIDANT STATUS; APOLIPOPROTEIN-E; CONTROLLED-TRIAL;
D O I
10.1097/gme.0b013e31827758c6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to examine the association between changes in blood oxidative stress level/activity and changes in memory performance among postmenopausal women. Methods: This study involved 39 postmenopausal women who received estrogen-progestin therapy (EPT) for 16 weeks. Verbal learning and memory performance were assessed using the Malay Version of Auditory Verbal Learning Test before and after 16 weeks of EPT. Oxidative stress levels/activities before and after 16 weeks of EPT were determined using commercially available kits. Data were analyzed using paired t test and r. P < 0.05 was considered significant. Results: The activities of glutathione peroxidase and catalase were considerably increased (P < 0.05), but the level of 4-hydroxynonenal was notably decreased (P < 0.05), after 16 weeks of EPT. There were positive correlations between changes in plasma superoxide dismutase and changes in trial A2 scores (r = 0.36, P < 0.05), and between changes in the ratio of blood reduced glutathione to oxidized glutathione and changes in trial A2 scores (r = 0.34, P < 0.05). Conclusions: Sixteen weeks of EPT increase blood antioxidant capacity. However, most of the changes in oxidative stress level/activity are not significantly associated with changes in the memory performance of postmenopausal women.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 50 条
  • [31] Estrogen-progestin replacement therapy and atherosclerosis
    Punnonen, R
    JOkela, H
    Dastidar, P
    Aine, R
    Laippala, P
    MATURITAS, 1996, 23 : S61 - S64
  • [32] Prevalence of estrogen or estrogen-progestin hormone therapy use
    Brett, KM
    Reuben, CA
    OBSTETRICS AND GYNECOLOGY, 2003, 102 (06): : 1240 - 1249
  • [33] THE EFFECT OF ESTROGEN-PROGESTIN TREATMENT ON OPIOID CONTROL OF GONADOTROPIN AND PROLACTIN SECRETION IN POSTMENOPAUSAL WOMEN
    DAWOOD, MY
    KHANDAWOOD, FS
    RAMOS, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (06) : 1246 - 1251
  • [34] Pilot study on the effect of estrogen-progestin replacement therapy on brain dopamine transporter activity in healthy, postmenopausal women
    Gardiner, SA
    Morrison, MF
    Mozley, PD
    Mozley, LH
    Brensinger, C
    Battistini, M
    Bilker, W
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 335 - 335
  • [35] INCIDENCE OF BREAST-CANCER IN A 22-YEAR STUDY OF WOMEN RECEIVING ESTROGEN-PROGESTIN REPLACEMENT THERAPY
    NACHTIGALL, MJ
    SMILEN, SW
    NACHTIGALL, RD
    NACHTIGALL, RH
    NACHTIGALL, LE
    OBSTETRICS AND GYNECOLOGY, 1992, 80 (05): : 827 - 830
  • [36] Estrogen-progestin replacement therapy and endometrial cancer
    Pike, MC
    Peters, RK
    Cozen, W
    ProbstHensch, NM
    Felix, JC
    Wan, PC
    Mack, TM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (15) : 1110 - 1116
  • [37] UPDATE ON CONTINUOUS ESTROGEN-PROGESTIN REPLACEMENT THERAPY
    ROSENFELD, JA
    AMERICAN FAMILY PHYSICIAN, 1994, 50 (07) : 1519 - 1523
  • [38] GYNECOLOGIC COMPLICATIONS OF CYCLIC ESTROGEN-PROGESTIN THERAPY
    ETTINGER, B
    SELBY, JV
    CITRON, JT
    ETTINGER, VM
    ZHANG, DY
    MATURITAS, 1993, 17 (03) : 197 - 204
  • [39] INCIDENCE OF BREAST-CANCER IN A 22-YEAR STUDY OF WOMEN RECEIVING ESTROGEN-PROGESTIN REPLACEMENT THERAPY
    GAMBRELL, RD
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (03): : 477 - 477
  • [40] Postmenopausal hormone therapy and risk of stroke - The Heart and Estrogen-progestin Replacement Study (HERS)
    Simon, JA
    Hsia, J
    Cauley, JA
    Richards, C
    Harris, F
    Fong, J
    Barrett-Connor, E
    Hulley, SB
    CIRCULATION, 2001, 103 (05) : 638 - 642